Skip to main content

Table 2 The relationship between PUFA intake and the prevalence of ED before and after PSM

From: Association between polyunsaturated fatty acid intake and the prevalence of erectile dysfunction: A cross-sectional analysis of the NHANES 2001–2004

Characteristics

Before PSM

After PSM

Model 1

OR (95% CI), P

Model 2

OR (95% CI), P

Model 3

OR (95% CI), P

Model 1

OR (95% CI), P

Model 2

OR (95% CI), P

Model 3

OR (95% CI), P

TPFA

0.98 (0.98, 0.99),

< 0.001

0.99 (0.98, 1.00),

< 0.001

0.99 (0.99, 1.00),

0.014

0.99 (0.99, 1.00),

0.076

0.99 (0.99, 1.00),

0.061

0.99 (0.99, 1.00),

0.091

ω-3 PUFA

0.88 (0.84, 0.92),

< 0.001

0.92 (0.87, 0.97),

0.001

0.94 (0.89, 0.99),

0.016

0.95 (0.90, 1.01),

0.120

0.95 (0.90, 1.01),

0.109

0.95 (0.90, 1.01),

0.125

ALA

0.86 (0.82, 0.91),

< 0.001

0.92 (0.86, 0.97),

0.004

0.94 (0.89, 1.00),

0.062

0.96 (0.89, 1.03),

0.224

0.95 (0.89, 1.02),

0.188

0.96 (0.89, 1.03),

0.248

SDA

0.45 (0.08, 2.61),

0.374

0.22 (0.04, 1.41),

0.111

0.20 (0.03, 1.36),

0.099

0.37 (0.04, 3.47),

0.385

0.41 (0.04, 3.90),

0.439

0.31 (0.03, 3.09),

0.319

EPA

0.73 (0.49, 1.09),

0.120

0.65 (0.42, 0.99),

0.046

0.62 (0.39, 0.97),

0.035

0.71 (0.42, 1.20),

0.199

0.72 (0.42, 1.22),

0.225

0.67 (0.39, 1.14),

0.142

DPA

0.27 (0.08, 0.93),

0.038

0.24 (0.07, 0.86),

0.028

0.24 (0.07, 0.91),

0.035

0.36 (0.08, 1.53),

0.164

0.40 (0.10, 1.69),

0.214

0.36 (0.08, 1.57),

0.174

DHA

0.80 (0.61, 1.05),

0.102

0.73 (0.55, 0.96),

0.025

0.74 (0.55, 0.98),

0.038

0.79 (0.56, 1.10),

0.159

0.80 (0.57, 1.11),

0.184

0.77 (0.55, 1.09),

0.142

ω-6 PUFA

0.98 (0.97, 0.99),

< 0.001

0.99 (0.98, 1.00),

< 0.001

0.99 (0.99, 1.00),

0.013

0.99 (0.99, 1.00),

0.079

0.99 (0.99, 1.00),

0.062

0.99 (0.99, 1.00),

0.094

LA

0.98 (0.97, 0.99),

< 0.001

0.99 (0.98, 1.00),

< 0.001

0.99 (0.99, 1.00),

0.015

0.99 (0.99, 1.00),

0.086

0.99 (0.99, 1.00),

0.068

0.99 (0.99, 1.00),

0.102

AA

0.23 (0.14, 0.37),

< 0.001

0.29 (0.17, 0.48),

< 0.001

0.33 (0.20, 0.56),

< 0.001

0.35 (0.19, 0.63),

< 0.001

0.34 (0.19, 0.63),

< 0.001

0.36 (0.20, 0.65),

< 0.001

  1. Notes: Bold fonts indicate P < 0.05. Model 1 was a crude model. Model 2 adjusted for age, BMI, race and education. Model 3 added hypertension, cardiovascular disease, diabetes, vigorous activity, moderate activity, and smoking status on the basis of Model 2. Abbreviations: PUFA, polyunsaturated fatty acid; TPFA, total polyunsaturated fatty acids; AA, arachidonic acid; ALA, α-linolenic acid; DHA, docosahexaenoic acid; LA, linoleic acid; EPA, eicosapentaenoic acid; DPA, docosapentaenoic acid; SDA, octadecanotetraenoic acid; PSM, propensity score matching; OR, odds ratio; CI, confidence interval
Back to article page

Lipids in Health and Disease

ISSN: 1476-511X